[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB9930813D0 - Anti-viral treatment - Google Patents

Anti-viral treatment

Info

Publication number
GB9930813D0
GB9930813D0 GBGB9930813.2A GB9930813A GB9930813D0 GB 9930813 D0 GB9930813 D0 GB 9930813D0 GB 9930813 A GB9930813 A GB 9930813A GB 9930813 D0 GB9930813 D0 GB 9930813D0
Authority
GB
United Kingdom
Prior art keywords
viral treatment
viral
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9930813.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henderson Morley Research and Development Ltd
Original Assignee
Henderson Morley Research and Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henderson Morley Research and Development Ltd filed Critical Henderson Morley Research and Development Ltd
Priority to GB0000683A priority Critical patent/GB0000683D0/en
Publication of GB9930813D0 publication Critical patent/GB9930813D0/en
Priority to GB0023200A priority patent/GB0023200D0/en
Priority to AT00981496T priority patent/ATE306275T1/en
Priority to EP00981496A priority patent/EP1242096B1/en
Priority to AU18731/01A priority patent/AU1873101A/en
Priority to JP2001549668A priority patent/JP2003519186A/en
Priority to CNB008180628A priority patent/CN1213757C/en
Priority to KR1020027008449A priority patent/KR20020073156A/en
Priority to DE60023180T priority patent/DE60023180D1/en
Priority to PCT/GB2000/004790 priority patent/WO2001049300A2/en
Priority to US10/168,946 priority patent/US20030049331A1/en
Priority to US11/240,343 priority patent/US20060029684A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9930813.2A 1999-10-15 1999-12-30 Anti-viral treatment Ceased GB9930813D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GB0000683A GB0000683D0 (en) 1999-10-15 2000-01-12 Antiviral treatment
GB0023200A GB0023200D0 (en) 1999-12-30 2000-09-21 Synergistic treatment of DNA viral infections
US10/168,946 US20030049331A1 (en) 1999-12-30 2000-12-13 Synergistic treatment of dna viral infections
AU18731/01A AU1873101A (en) 1999-12-30 2000-12-13 Synergistic treatment of dna viral infections
EP00981496A EP1242096B1 (en) 1999-12-30 2000-12-13 Pharmaceutucal compositions for the treatment of dna viral infections comprising a loop diuretic and lithium
AT00981496T ATE306275T1 (en) 1999-12-30 2000-12-13 PHARMACEUTICAL PREPARATIONS FOR TREATING DNA OF VIRAL INFECTIONS, WHICH CONTAIN A LOOP DIURETIC AND LITHIUM
JP2001549668A JP2003519186A (en) 1999-12-30 2000-12-13 Synergistic treatment of DNA virus infection
CNB008180628A CN1213757C (en) 1999-12-30 2000-12-13 Combinations for treatment of DNA viral infections
KR1020027008449A KR20020073156A (en) 1999-12-30 2000-12-13 Synergistic treatment of dna viral infections
DE60023180T DE60023180D1 (en) 1999-12-30 2000-12-13 PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DNA VIRAL INFECTIONS CONTAINING A GRANGE DIITHIUM AND LITHIUM
PCT/GB2000/004790 WO2001049300A2 (en) 1999-12-30 2000-12-13 Combinations for the treatment of dna viral infections comprising a loop diuretic and lithium
US11/240,343 US20060029684A1 (en) 1999-12-30 2005-09-30 Synergistic treatment of DNA viral infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9924389A GB2355192A (en) 1999-10-15 1999-10-15 Anti-viral treatment

Publications (1)

Publication Number Publication Date
GB9930813D0 true GB9930813D0 (en) 2000-02-16

Family

ID=10862777

Family Applications (3)

Application Number Title Priority Date Filing Date
GB9924389A Withdrawn GB2355192A (en) 1999-10-15 1999-10-15 Anti-viral treatment
GBGB9930813.2A Ceased GB9930813D0 (en) 1999-10-15 1999-12-30 Anti-viral treatment
GBGB9930811.6A Ceased GB9930811D0 (en) 1999-10-15 1999-12-30 Anti-viral treatment

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB9924389A Withdrawn GB2355192A (en) 1999-10-15 1999-10-15 Anti-viral treatment

Family Applications After (1)

Application Number Title Priority Date Filing Date
GBGB9930811.6A Ceased GB9930811D0 (en) 1999-10-15 1999-12-30 Anti-viral treatment

Country Status (1)

Country Link
GB (3) GB2355192A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0517840D0 (en) * 2005-09-02 2005-10-12 Henderson Morley Plc Topical anti viral formulations
GB0517838D0 (en) * 2005-09-02 2005-10-12 Henderson Morley Plc Transdermal active principle delivery means
WO2015089494A1 (en) * 2013-12-13 2015-06-18 Ankenman Ralph Compositions and methods for treating dysregulated systems
CN115463146B (en) * 2022-10-14 2024-01-23 浙大城市学院 Application of ouabain compound in preparation of antiviral drugs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8320203D0 (en) * 1983-07-27 1983-09-01 Horrobin D F Anti-viral compositions
CA2013843A1 (en) * 1989-04-06 1990-10-06 Junko Nozaki Antiviral composition
JPH03240732A (en) * 1990-02-14 1991-10-28 Yasuo Tanaka Antiviral agent

Also Published As

Publication number Publication date
GB2355192A (en) 2001-04-18
GB9930811D0 (en) 2000-02-16
GB9924389D0 (en) 1999-12-15

Similar Documents

Publication Publication Date Title
HK1054816A1 (en) Solution processing
DE60037335D1 (en) Polymerizationsverfahren
GB0009915D0 (en) Solution processing
DE50000137D1 (en) Spirofluorenopyrane
GB9925136D0 (en) Novel treatment
GB9918760D0 (en) Topical treatment
IL144186A0 (en) Novel treatment
GB9922830D0 (en) Processes
GB0003284D0 (en) Anti-viral therapy
GB0012739D0 (en) Bath
GB9930811D0 (en) Anti-viral treatment
GB9914798D0 (en) Ensure
GB0027081D0 (en) Solution
AU140373S (en) Bumbag
GB0206401D0 (en) Side effects treatment
GB9908993D0 (en) Treatment
GB9906211D0 (en) Anti-viral compounds
GB0000683D0 (en) Antiviral treatment
GB9909650D0 (en) Novel treatment
GB9916655D0 (en) Novel treatment
GB9920787D0 (en) Novel treatment
GB9920788D0 (en) Novel treatment
GB2351657B (en) Concealed-tap bath
CA87158S (en) Pendulette
GB9923740D0 (en) Surface treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)